Samuels Theodore R. II 4

What Happened

• Theodore R. Samuels II, a member of the Board of Directors of Bristol Myers Squibb (BMY), was granted 845.012 deferred share units (DSUs) on March 31, 2026. The DSUs are reported as a derivative award valued at $60.65 per share, for a total reported value of $51,250. This was an award (compensation) — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Report filed: 2026-04-02 (filed within the normal Form 4 reporting window).
• Security/amount: 845.012 Deferred Share Units (derivative) at $60.65 each; total value $51,250.
• Transaction code: A (award/grant/acquisition).
• Shares owned after transaction: Not reported in this filing.
• Footnotes:
  • F1: Each DSU will convert into a share of common stock upon settlement; DSUs become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
  • F2: Amount includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Context

• DSUs are a form of deferred compensation for non-employee directors. They represent the right to receive shares in the future (on settlement) rather than an immediate cash purchase or sale; they generally do not indicate current market buying or selling by the insider.